Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
about
BMI and BMD: The Potential Interplay between Obesity and Bone FragilityTestosterone Deficiency and Nocturia: A Review.Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily.Aging and sexual health: getting to the problem.The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms.Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology.Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage.Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia.Levels of uric acid in erectile dysfunction of different aetiology.Comparison of the effectiveness of IPSS and VPSS without any help in LUTS patients: a prospective study.Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia.Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study.The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study.Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men.Relationship between serum testosterone and nocturia in men without benign prostate enlargement.Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.Increased visceral adiposity index associated with sexual dysfunction in men.Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release.The role of sex steroid hormones in benign prostatic hyperplasia.Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study.The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.
P2860
Q26744811-0A589B9B-5829-4844-BA56-967097D96885Q33642001-CBC84DD4-FF6C-4D94-8923-2375E7D6CE4BQ36304676-3B343C3E-E2FE-4BB5-93A4-6D0C1FE5E917Q38620085-26EA50CC-8E52-42FC-8622-83322D7688EAQ38738470-778F76A9-AB63-4C2F-8548-2AADBF8EB5FAQ39027722-71B45CCD-BCB3-4EB8-A865-CCF2C182D4B5Q39104684-CBC63B50-6733-44B3-8BB0-3F7B7902618DQ46573653-3FC738F6-212D-477A-9AB1-7788874DAD3FQ47176848-1E81C12B-0D51-416D-B400-93672C397305Q47243697-B37DDD0A-39AD-4FE6-8497-CEA3CF1F0F9AQ47302527-6B189F9C-23FA-4013-8DD4-58DD40F08310Q47704305-97301AE3-C1D0-4AAB-9181-12F434FBA709Q47803340-0481B0A7-4D9A-4909-990F-E1A71A6AB9DBQ48519012-59ABA99B-E3C9-407C-911B-C4AC6F653AD7Q48538834-DFA12329-A61E-49A6-8E3D-305AEAF514E9Q48601812-43B6D816-441C-49C1-B515-C29A370E59C0Q48602734-0A00D2A8-F229-45DF-AC4D-E7435F31A980Q48678512-FE5B71A7-6038-4243-A7F0-4C75E3D21C13Q48712649-E28A5428-FF8F-4F6B-AA53-B8BF4053EADEQ48793783-31353E73-E30A-4E3F-A330-3F9A5CA84C8AQ48864228-2A84FEDF-EE20-4B63-A092-2F648C9C2B6EQ49791495-36E23BDA-7DBE-4ED8-9C09-D34206E35097Q50897539-3416D090-271E-4844-8269-4521B33AB2C1Q51193265-BBECC3E5-A25B-4616-B381-9D04AFF53F86Q53105584-479D5AD4-6351-4BD8-A03A-A45AC1C1A94AQ53160861-11529205-7137-42FB-8A76-5521447D7AFB
P2860
Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Effects of testosterone replac ...... nd prostate safety parameters.
@en
Effects of testosterone replac ...... nd prostate safety parameters.
@nl
type
label
Effects of testosterone replac ...... nd prostate safety parameters.
@en
Effects of testosterone replac ...... nd prostate safety parameters.
@nl
prefLabel
Effects of testosterone replac ...... nd prostate safety parameters.
@en
Effects of testosterone replac ...... nd prostate safety parameters.
@nl
P2093
P2860
P1433
P1476
Effects of testosterone replac ...... nd prostate safety parameters.
@en
P2093
Aksam Yassin
Gheorge Doros
Joanne E Nettleship
Raidh A Talib
Yousef Almehmadi
P2860
P356
10.3109/13685538.2015.1126573
P577
2016-01-08T00:00:00Z